Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2015, Article ID 273565, 5 pages
http://dx.doi.org/10.1155/2015/273565
Case Report

Localized Relapse of Primary Plasma Cell Leukaemia in the Central Nervous System

Department of Haematology, Aarhus University Hospital, Aarhus, Denmark

Received 10 March 2015; Accepted 17 April 2015

Academic Editor: Gandhi Damaj

Copyright © 2015 Christian W. Eskelund and Niels Frost Andersen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. García-Sanz, A. Orfão, M. González et al., “Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics,” Blood, vol. 93, no. 3, pp. 1032–1037, 1999. View at Google Scholar · View at Scopus
  2. M. A. Dimopoulos, A. Palumbo, K. B. Delasalle, and R. Alexanian, “Primary plasma cell leukaemia,” British Journal of Haematology, vol. 88, no. 4, pp. 754–759, 1994. View at Publisher · View at Google Scholar · View at Scopus
  3. R. A. Kyle, J. E. Maldonado, and E. D. Bayrd, “Plasma cell leukemia. Report on 17 cases,” Archives of Internal Medicine, vol. 133, no. 5, pp. 813–818, 1974. View at Publisher · View at Google Scholar · View at Scopus
  4. R. E. Tiedemann, N. Gonzalez-Paz, R. A. Kyle et al., “Genetic aberrations and survival in plasma cell leukemia,” Leukemia, vol. 22, no. 5, pp. 1044–1052, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. G. D'Arena, C. G. Valentini, G. Pietrantuono et al., “Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA multiple Myeloma Working Party,” Annals of Oncology, vol. 23, no. 6, pp. 1499–1502, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. M. B. Drake, S. Iacobelli, A. van Biezen et al., “Primary plasma cell leukemia and autologous stem cell transplantation,” Haematologica, vol. 95, no. 5, pp. 804–809, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Pagano, C. G. Valentini, V. de Stefano et al., “Primary plasma cell leukemia: a retrospective multicenter study of 73 patients,” Annals of Oncology, vol. 22, no. 7, pp. 1628–1635, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Avet-Loiseau, A. Daviet, C. Brigaudeau et al., “Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myélome and the Groupe Français de Cytogénétique Hématologique,” Blood, vol. 97, no. 3, pp. 822–825, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Turhal, M. D. Henehan, and K. L. Kaplan, “Multiple myeloma: a patient with unusual features including intracranial and meningeal involvement, testicular involvement, organomegaly, and plasma cell leukemia,” American Journal of Hematology, vol. 57, no. 1, pp. 51–56, 1998. View at Google Scholar · View at Scopus
  10. X. Leleu, J. P. Jouet, I. Plantier et al., “Isolated neurological relapse following stem cell transplantation in plasma cell leukemia: a report of two cases,” Leukemia, vol. 13, no. 2, pp. 307–309, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. S. L. Petersen, A. Wagner, and P. Gimsing, “Cerebral and meningeal multiple myeloma after autologous stem cell transplantation. A case report and review of the literature,” American Journal of Hematology, vol. 62, no. 4, pp. 228–233, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Wellwood, K. Taylor, S. Wright et al., “Relapsed plasma cell leukaemia presenting with aggressive extramedullary plasmacytomas in the meninges and testis—a missed opportunity for induction CNS prophylaxis,” Leukemia & Lymphoma, vol. 43, no. 4, pp. 893–896, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. N. W. C. J. van de Donk, H. M. Lokhorst, K. C. Anderson, and P. G. Richardson, “How I treat plasma cell leukemia,” Blood, vol. 120, no. 12, pp. 2376–2389, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. A. B.-T. Fassas, F. Muwalla, T. Berryman et al., “Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations,” British Journal of Haematology, vol. 117, no. 1, pp. 103–108, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. A. O. Abdallah, S. Atrash, Z. Shahid et al., “Patterns of central nervous system involvement in relapsed and refractory multiple myeloma,” Clinical Lymphoma, Myeloma & Leukemia, vol. 14, no. 3, pp. 211–214, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. C. I. Chen, E. Masih-Khan, H. Jiang et al., “Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents,” British Journal of Haematology, vol. 162, no. 4, pp. 483–488, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. C. F. de Larrea, R. A. Kyle, B. G. M. Durie et al., “Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group,” Leukemia, vol. 27, no. 4, pp. 780–791, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Royer, F. Magrangeas, B. Lioure, J. Fermand, C. Hulin, and L. Karlin, “First large prospective study for patients with primary plasma cell leukemia: bortezomib-doxorubicin-dexamethasone/bortezomib-cyclophosphamide-dexamethasone regimens as induction before stem cell transplantation followed by consolidation with lenalidomide-bortezomib-dex or allograft (a study of the IFM group),” in Proceedings of the ASH 2013 Annual Meeting, Abstract 761, 2013.